Clearance Summary
Chemfort CSTD received FDA 510(k) clearance under submission number K192866, sponsored by Simplivia Healthcare , Ltd.. The device was reviewed via the Abbreviated premarket notification pathway and assigned to the General Hospital review panel. The statutory decision date of record is 2020-05-07.
- Submission: K192866
- Applicant / Sponsor: Simplivia Healthcare , Ltd.
- Clearance pathway: Abbreviated
- Review panel: General Hospital
- Device class: Class II
- Regulation citation: 21 CFR 880.5440
- Decision date: 2020-05-07
Classification & Regulation
This clearance is catalogued under FDA product code ONB and 21 CFR 880.5440, within the General Hospital review panel as a Class II device.